---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-005677"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2025-02-10T23:59:59+00:00"
generated_at: "2026-05-27T00:13:48.172517+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# INBS reports prelim Q2 revenue ~$0.61M; gross margin up to 38.5%; FDA 510(k) submitted for U.S. market entry in 2025

## Summary
- Preliminary Q2 FY2025 revenue ~$0.61M; 6-month revenue ~$1.48M; gross profit margin improved to 38.5% from 27.7%.
- Fiscal year 2024 revenues grew 148% YoY; over 400 accounts in 19 countries with customer employee base ~1.4M.
- Submitted 510(k) pre-market notification to FDA in Dec 2024; on track for U.S. market entry in 2025.
- PK study showed fingerprint sweat correlates with blood at 95% confidence; Method Comparison Study showed ~94% accuracy.
- Gross profit up 32.6% to $0.57M for six months; strategic focus on higher-margin cartridge sales driving margin expansion.

## SEC filing metadata
- accession: 0001493152-25-005677
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2025-02-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315225005677/0001493152-25-005677-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315225005677/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-005677
- JSON: https://secwatch.observer/filing/0001493152-25-005677.json
- Plain text: https://secwatch.observer/filing/0001493152-25-005677.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.